Tempus AI, Inc. (NASDAQ:TEM - Get Free Report)'s share price hit a new 52-week high on Tuesday . The company traded as high as $79.02 and last traded at $77.79, with a volume of 334848 shares changing hands. The stock had previously closed at $77.62.
Wall Street Analyst Weigh In
A number of brokerages have recently weighed in on TEM. Loop Capital raised their price objective on Tempus AI from $48.00 to $57.00 and gave the company a "buy" rating in a research report on Tuesday, October 15th. Needham & Company LLC reiterated a "buy" rating and issued a $47.00 price target on shares of Tempus AI in a research report on Wednesday, August 7th. Bank of America lowered Tempus AI from a "buy" rating to a "neutral" rating and lifted their price target for the stock from $45.00 to $60.00 in a research report on Wednesday, October 2nd. Stifel Nicolaus lowered Tempus AI from a "buy" rating to a "hold" rating and lifted their price target for the stock from $45.00 to $65.00 in a research report on Monday. Finally, JPMorgan Chase & Co. lifted their price target on Tempus AI from $42.00 to $47.00 and gave the stock an "overweight" rating in a research report on Wednesday, August 7th. Three research analysts have rated the stock with a hold rating and seven have given a buy rating to the stock. According to MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and an average price target of $54.22.
Check Out Our Latest Stock Analysis on TEM
Tempus AI Price Performance
The company has a quick ratio of 3.52, a current ratio of 2.69 and a debt-to-equity ratio of 8.17. The company's 50-day simple moving average is $50.58.
Institutional Investors Weigh In On Tempus AI
Several hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. First Horizon Advisors Inc. acquired a new stake in Tempus AI during the 3rd quarter worth about $30,000. Vestor Capital LLC acquired a new stake in Tempus AI during the 3rd quarter worth about $153,000. Sandia Investment Management LP acquired a new stake in Tempus AI during the 2nd quarter worth about $136,000. IQ EQ FUND MANAGEMENT IRELAND Ltd acquired a new stake in shares of Tempus AI during the 3rd quarter valued at about $258,000. Finally, Clarus Group Inc. acquired a new stake in shares of Tempus AI during the 3rd quarter valued at about $283,000.
Tempus AI Company Profile
(
Get Free Report)
Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.
Read More
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Tempus AI, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Tempus AI wasn't on the list.
While Tempus AI currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
